Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. (Q45975745)

18 December 2017

title

Liver damage is not reversed during the lean period in diet-induced weight cycling in mice. (English)

1 reference

18 December 2017

Carlos A Mandarim-de-Lacerda

author

0 references

author name string

Sandra Barbosa-da-Silva

1

1 reference

18 December 2017

Natalia C da Silva

2

1 reference

18 December 2017

Marcia B Aguila

3

1 reference

18 December 2017

Carlos A Mandarim-de-Lacerda

4

1 reference

18 December 2017

publication date

22 May 2013

1 reference

18 December 2017

published in

Hepatology Research

1 reference

18 December 2017

volume

44

1 reference

18 December 2017

issue

4

1 reference

18 December 2017

page(s)

450-459

1 reference

18 December 2017

Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity

cites work

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Weight cycling enhances adipose tissue inflammatory responses in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Weight change, weight fluctuation, and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

From the metabolic syndrome to NAFLD or vice versa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

PPARalpha: energy combustion, hypolipidemia, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

A critical analysis of three quantitative methods of assessment of hepatic steatosis in liver biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

A simple tool for stereological assessment of digital images: the STEPanizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Variability of body weight and health outcomes in the Framingham population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Pathology of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

The histologic spectrum of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Hepatic triglyceride synthesis and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Nonalcoholic fatty liver disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Adipose tissue, liver and pancreas structural alterations in C57BL/6 mice fed high-fat-high-sucrose diet supplemented with fish oil (n-3 fatty acid rich oil).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Steatosis recovery after treatment with a balanced sunflower or olive oil-based diet: involvement of perisinusoidal stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Fatty liver and lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12138

21 January 2018

Identifiers

DOI

10.1111/HEPR.12138

1 reference

18 December 2017

PubMed ID

23607320

1 reference

18 December 2017